phenyl acetate has been researched along with calcium acetate in 182 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (3.85) | 18.7374 |
| 1990's | 5 (2.75) | 18.2507 |
| 2000's | 84 (46.15) | 29.6817 |
| 2010's | 75 (41.21) | 24.3611 |
| 2020's | 11 (6.04) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, V; Yang, T | 1 |
| Gruenhagen, SE; Magnusen, HM; Martin, BR; Peck, LW; Schulze, DG; Weaver, CM | 1 |
| Böttger, WM; Gelens, MA; Kaufmann, BG; Klaassen, HA; van den Bergh, JP; Verstappen, VM | 1 |
| Albu, AT; Dungaciu, M; El Esper, N; Fournier, A; Mornière, P; Oprisiu, R | 1 |
| Llach, F; Yudd, M | 1 |
| Gropper, SS; Soffer, O; Yates, LA | 1 |
| Chen, JS; Chen, PY; Chen, WY; Chung Wu, D; Huang, CL; Huang, JW; Hung, KY; Kan, YT; Lee, SH; Leu, LJ; Yang, CS | 1 |
| Bondre, S; Gresser, JD; Lewandrowski, KU; Silva, AE; Trantolo, DJ; Wise, DL | 1 |
| Heicappell, R; Miller, K; Müller, M; Schrader, M; Straub, B | 1 |
| Kim, SH; Schulze-Gahmen, U | 1 |
| During, MJ; Janson, CG; Leone, P; McPhee, SJ | 1 |
| Dennis, VW; Fatica, RA | 1 |
| Malluche, HH; Mawad, H | 1 |
| Bledsoe, AL; Kaplan, MR; McGowan, J; Stashenko, CL | 1 |
| Bay, WH; Coyle, JD; Hoshaw-Woodard, S; Pruchnicki, MC | 1 |
| Cleveland, M | 1 |
| Martin, CJ; Reams, SM | 1 |
| Cerezo, S; Hervás, JG; Prados, D | 1 |
| Neme, G; Peñalba, A; Tirado, S | 1 |
| Bleyer, AJ | 2 |
| Nolan, CR; Qunibi, WY | 3 |
| Goudas, PC | 1 |
| FLIES, A | 1 |
| BAJUSZ, E; LEMIRE, Y; RENAUD, S; SELYE, H | 1 |
| PRIORESCHI, P; SELYE, H | 1 |
| ORTEGA, MR; SELYE, H; TUCHWEBER, B | 1 |
| Paret, CL | 1 |
| Kays, MB; Moe, SM; Mueller, BA; Overholser, BR; Sowinski, KM | 1 |
| Cai, J; Wastney, ME; Weaver, CM; Zhang, Q | 1 |
| Oztürk, I; Yilmaz, G | 1 |
| Bommer, J; Chertow, GM; Raggi, P | 1 |
| BANNINK, HF; MULLER, FM | 1 |
| FERRARO, A; ROIZIN, L | 1 |
| Cleveland, MV; Garza, RO; He, DY; Hootkins, RE; McDowell, LL; Meyer, MS; Muenz, LR; Nolan, CR; Pelham, RW; Qunibi, WY; Simon, M | 1 |
| Adamsone, I; Amerika, D; Babarykin, D; Berzina, N; Michule, L; Moisejev, V; Rozental, R; Spudass, A | 1 |
| Kotzekidou, P; Tsapatsaris, S | 1 |
| MANTEN, A; MULLER, FM; NOORDAM-GOEDEWAGEN, MA | 1 |
| González, A; Martín, F; Martínez, F; Sarró, F; Verdú, J | 1 |
| Fouque, D | 1 |
| Cobanoglu, B; Coskun, B; Karincaoglu, Y; Ozturk, P; Saral, Y | 1 |
| Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
| Milthorpe, BK; Ruys, AJ; Sorrell, CC; Wei, M | 1 |
| Friedman, EA | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Kuramoto, K; Miyazaki, T; Mori, A; Ohtsuki, C; Osaka, A; Sugino, A; Tanihara, M | 1 |
| Arun, P; Madhavarao, CN; Mathew, R; Moffett, JR; Namboodiri, MA | 1 |
| Akçay, A; Arat, Z; Elsurer, R; Haberal, M; Ozdemir, FN; Sezer, S | 1 |
| Kang, IK; Kim, KH; Kim, S; Kim, SY; Kwon, TY; Ong, JL; Yang, Y | 1 |
| Kuramoto, K; Miyagi, J; Moriya, H; Ohtsuki, C; Sugino, A; Suzuki, M; Tsukeoka, T; Tsuneizumi, Y | 1 |
| Bonzel, KE; Dittrich, K; Düker, G; Fründ, S; Haffner, D; Hoppe, B; John, U; Klaus, G; Offner, G; Pieper, AK; Querfeld, U; Stübinger, A | 1 |
| Geurkink, E; Haight, M; Westanmo, AD | 1 |
| Qunibi, WY | 1 |
| Little, G; Otoo, A | 1 |
| Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
| Drüeke, TB; Landais, P | 1 |
| Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
| Méndez De Leo, LP; Wood, RH | 1 |
| Chen, J; Geis-Gerstorfer, J; Scheideler, L; Zhu, XL | 1 |
| Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
| Burton, MA; Kennedy, RA; Sriamornsak, P | 1 |
| Frost, RL; Musumeci, AW; Waclawik, ER | 1 |
| Cen, KF; Liu, J; Liu, JZ; Xiao, HP; Zhou, JH | 1 |
| Chou, CY; Huang, CC; Kuo, HL; Liao, PY; Lin, HH; Lin, PW; Liu, JH; Liu, YL; Yang, YF; Yu, CC | 1 |
| Carter, TB; Dansby, LM; Diskin, CJ; Radcliff, L; Stokes, TJ | 1 |
| Korkerd, K; Sriamornsak, P; Thirawong, N | 1 |
| Avnir, Y; Barenholz, Y; Gabizon, A; Kost, J; Najajreh, Y; Schroeder, A; Talmon, Y; Weisman, S | 1 |
| Armstrong, A; Li, J; Lykidis, D; Spencer-Dene, B; Stamp, GW; Van Noorden, S; Zhuang, Z | 1 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Grant, DM; Harper, JK; Strohmeier, M | 1 |
| Acikel, C; Axelsson, J; Caglar, K; Cakir, E; Carrero, JJ; Eyileten, T; Lindholm, B; Oguz, Y; Saglam, M; Stenvinkel, P; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Barreto, DV; Barreto, FC; Canziani, ME; Carvalho, AB; Draibe, SA; Jorgetti, V; Moysés, RM; Neves, KR | 1 |
| Tonelli, M; Winkelmayer, WC | 1 |
| Fan, Q; Liu, J; St Peter, WL; Weinhandl, E | 2 |
| Budoff, M; Diaz-Buxo, JA; He, DY; Kessler, PD; Moustafa, M; Muenz, LR; Qunibi, W | 1 |
| Chen, B; Chen, D; Hu, H; Lu, W; Qiao, M; Qin, J; Xu, H; Yan, C; Zhao, X | 1 |
| Floege, J | 1 |
| Miyazaki, T; Ohtsuki, C; Sugino, A | 1 |
| Caputo, F; Chasan-Taber, S; Duggal, A; Evenepoel, P; Fan, S; Foggensteiner, L; Heaf, JG; Kelly, A; Ortiz, A; Selgas, R | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Carvalho, AB; Cuppari, L; Dalboni, MA; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Li, JT; Sun, BM; Xiao, HP; Ye, LP; Zhou, JH | 1 |
| Muenz, LR; Qunibi, W | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Cuppari, L; Dalboni, MA; de Carvalho, AB; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| De Vos, JY; Elseviers, M | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Khan, DA; Khan, FA; Saif, I | 1 |
| Shigematsu, T; Skaguchi, T | 1 |
| Andreoli, MC; Batista, MC; Canziani, ME; Carvalho, AB; Carvalho, JT; Cendoroglo, M; Cuppari, L; Dalboni, MA; Draibe, SA; Guimarães, N; Jorgetti, V; Manfredi, SR; Moyses, RM; Peres, AT | 1 |
| Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Tsuyuki, RT | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; Dos Reis, LM; Draibe, SA; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Bagga, A; Bose, T; Gulati, A; Hari, P; Sridhar, V | 1 |
| Gotch, F; Kotanko, P; Levin, NW | 1 |
| Buhrman, G; Fetics, S; Holzapfel, G; Mattos, C | 1 |
| Jespersen, L; Olesen, I; Thorsen, L | 1 |
| Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
| Enomoto, H; Jin, F; Jin, Y; Kishita, A; Watanabe, Y; Zhang, G | 1 |
| Benedyk-Lorens, E; Covic, AC; de Francisco, AL; Ketteler, M; Leidig, M; Mircescu, GM; Passlick-Deetjen, J; Ponce, P; Scholz, C | 1 |
| Noto, L | 1 |
| Álvarez-Ude, F; Arenas, MD; Gil, MT; Malek, T; Moledous, A; Reig-Ferrer, A | 1 |
| Kim, TH; Yang, SY | 1 |
| Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Bondor, C; Brumboiu, A; Gherman-Caprioara, M; Kacso, I; Moldovan, D; Moldovan, I; Orasan, R; Parvu, L; Patiu, IM; Racasan, S; Rusu, C | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Kestenbaum, B; Liu, J; Winkelmayer, WC | 1 |
| Nurulaini, H; Wong, TW | 2 |
| Diaz-Buxo, JA; Greenberg, J; Ho, CH; Kessler, P; Moustafa, M; Qunibi, W; Solomon, R; Winkelmayer, WC | 1 |
| Chandraker, A; Grafals, M; Rennke, HG; Riella, LV | 1 |
| Grant, JB; Harless, ML; Huckins, CJ; Pypker, TG | 1 |
| Biyik, Z; Demircioglu, S; Ozbek, O; Solak, Y; Turk, S | 1 |
| Carlson, HE; Zamfirescu, I | 1 |
| Fujisawa, T; Hara, H; Hironaka, K; Sasaki, H; Shimazawa, M; Takeuchi, H; Tozuka, Y; Tsuruma, K | 1 |
| Cazaña-Pérez, V; Donate-Correa, J; García-Pérez, J; Mora-Fernández, C; Muros de Fuentes, M; Navarro-González, JF | 1 |
| Brenchley, PE; Hutchison, AJ; Smith, CP | 1 |
| Caglar, K; Eyileten, T; Kilic, S; Mallamaci, F; Oguz, Y; Saglam, M; Sonmez, A; Vural, A; Yaman, H; Yenicesu, M; Yilmaz, MI; Zoccali, C | 1 |
| Jaber, BL; Susantitaphong, P | 1 |
| Avciata, O; Kaya, C; Kaya, F; Ustundag, CB | 1 |
| Drüeke, TB; Massy, ZA | 1 |
| Allison, MA; Asplin, J; Block, GA; Chertow, GM; Hoofnagle, AN; Kestenbaum, B; Ketteler, M; Kooienga, L; Mannstadt, M; Persky, MS; Smits, G; Spiegel, DM; Thadhani, R; Wheeler, DC; Wolf, M | 1 |
| Buhrman, G; Holzapfel, G; Mattos, C | 1 |
| Huml, AM; Leon, JB; Sehgal, AR; Sullivan, CM | 1 |
| Evenepoel, P; Meijers, B | 1 |
| Chang, H; Lin, SH; Wang, YT; Wu, TJ | 1 |
| Bernard, LM; Dunn, ES; Grima, DT; Mendelssohn, DC | 1 |
| Binswanger, U; Hess, B | 1 |
| Cowie, H; de Poot, S; Gorman Ng, M; Schmid, K; Semple, S; van Tongeren, M | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
| Chen, CZ; Pan, YK; Wang, DG; Zhao, TG | 1 |
| Büschges-Seraphin, B; Covic, A; de Francisco, AL; Ghenu, A; Kroczak, M; Marzell, B; Passlick-Deetjen, J; Ponce, P | 1 |
| Chatterley, T; Dorgan, M; Fitchett, D; Jamal, SA; Lok, CE; Mendelssohn, DC; Raggi, P; Tsuyuki, RT; Vandermeer, B | 1 |
| Allison, SJ | 1 |
| Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; de Oliveira, RB; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM | 1 |
| Bennett-Jones, D; Dasgupta, I; McVeigh, G; Shroff, R | 1 |
| Cowie, H; de Poot, S; Ng, MG; Schmid, K; Semple, S; van Tongeren, M | 1 |
| St Peter, WL; Weinhandl, ED; Yusuf, AA | 1 |
| Alfieri, T; Anum, EA; Braunhofer, P; Newsome, B; Ramakrishnan, K; Wang, S | 1 |
| Donadio, D; Kahlen, J; Peter, C; Salimi, L; Sulpizi, M | 1 |
| Abad, S; Arroyo, D; López-Gómez, JM; Panizo, N; Pérez-de José, A; Vega, A | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Barenholz, Y; Cern, A; Goldblum, A; Nativ-Roth, E | 1 |
| Castanheira, L; Celis, JP; Chakar, C; Changotade, S; Felgueiras, HP; Henriques, M; Lutomski, D; Migonney, V; Naaman, N; Oughlis, S; Poirier, F; Ponthiaux, P; Rocha, LA; Younes, R | 1 |
| Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
| Albines, Z; Arias, M; Belmar, L; de Francisco, AL; Kislikova, M; Piñera, C; Sango, C; Seras, M; Serrano, M | 1 |
| Duan, F; Huang, Y; Zhang, L | 1 |
| Liu, J; Miyazaki, T; Shirosaki, Y | 1 |
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
| Hu, Y; Liu, Z; Pan, H; Tang, R; Wang, Y; Xu, X; Zhao, H | 1 |
| Huang, Y; Mao, Z; Wang, Y; Xie, G; Yang, B; Zhang, H | 1 |
| Aina, OO; Lamprecht, A; Odeku, OA; Okunlola, A; Oridupa, OA; Oyagbemi, AA | 1 |
| Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Dwyer, JP; Fadem, SZ; Goral, S; Greene, T; Koury, M; Lewis, JB; Middleton, J; Sika, M; Sinsakul, MV; Umanath, K; Van Buren, PN; Weiner, DE | 1 |
| Bose, A; Dan, S; Harjoh, N; Pal, TK; Wong, TW | 1 |
| Guo, X; Liu, X; Liu, Z; Ma, W; Su, G; Wu, Y; Xu, Y; Yang, Q; Zhang, L; Zou, C | 1 |
| Giannakopoulou, T; Giannouri, M; Lekakou, C; Todorova, N; Trapalis, C; Vermisoglou, EC | 1 |
| Aires, I; Amaral, T; Azevedo, A; Ferreira, A; Ferreira, C; Gil, C; Jorge, C; Laranjinha, I; Matias, PJ; Mendes, M; Navarro, D; Stuard, S | 1 |
| Copland, M; Komenda, P; McCullough, PA; Morfin, JA; Weinhandl, ED | 1 |
| Egorkin, VS; Gnedenkov, SV; Kostiv, RE; Puz, AV; Sinebryukhov, SL | 1 |
| Cho, JH; Choi, JY; Jang, HM; Jin, DC; Jung, HY; Kim, CD; Kim, YL; Park, SH; Yang, CW | 1 |
| Brehm-Stecher, B; Colonna, W; Pometto, A; Shetty, K | 1 |
| Neradova, A; Schumacher, SP; Schurgers, LJ; Vervloet, MG | 1 |
| Huynh, T; Nguyen, T; Pham, T | 1 |
| Garduño-Pineda, L; Linares-Hernández, I; Martínez-Miranda, V; Solache-Ríos, MJ; Teutli-Sequeira, A | 1 |
| Thiravetyan, P; Treesubsuntorn, C | 1 |
| Chen, L; Chen, X; Li, T; Liang, T; Lin, Y; Liu, Z; Luo, Y; Sun, X; Wang, J; Ye, Y; Zhong, Z | 1 |
| Dong, Y; Li, M; Li, X; Liu, Q; Xu, J; Zhi, H | 1 |
| Baqdunes, MW; Clark, B; Kunkel, GM | 1 |
| Chamberlain, S; Mole, DR; Protheroe, A; Purshouse, K; Soares, M; Tuthill, M | 1 |
| Fujioka, K; Gong, JP; Hong, W; Lee, YW; Nonoyama, T; Ota, K | 1 |
| Clark, S; Fei, T; Price, N; Wang, T | 1 |
| Al-Amin, MD; Bellato, F; Caliceti, P; Garofalo, M; Malfanti, A; Mastrotto, F; Salmaso, S | 1 |
| Block, GA; Chertow, GM; Chonchol, M; de Boer, IH; Ginsberg, C; Hoofnagle, A; Kestenbaum, B; Zelnick, LR | 1 |
| Gutmann, JL; Kazerani, H; Morgano, SM; Saghiri, MA | 1 |
| Boonsuan, W; Chainakun, P; Ekprasert, J; Fongkaew, I; Kamngam, R | 1 |
| Maeda, T; Miyazaki, T; Wang, H | 1 |
| Barroso-Fernandez, B; den Adel, M; Golor, G; Groenendaal-van de Meent, D; Kerbusch, V; Schaddelee, M; van Dijk, J | 1 |
| Godugu, K; Mason, DL; Mousa, SA; Nnani, D | 1 |
| Araujo, R; Bancu, I; Bonal, J; Graterol, F; Merino-Ribas, A; Noguera-Julian, M; Paredes, R; Sampaio-Maia, B; Vergara, A | 1 |
23 review(s) available for phenyl acetate and calcium acetate
| Article | Year |
|---|---|
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
Topics: Acetates; Acetazolamide; Amidohydrolases; Animals; Aspartic Acid; Brain; Brain Edema; Calcium Compounds; Canavan Disease; Child; Child, Preschool; Cholesterol; Combined Modality Therapy; Cytomegalovirus; Dependovirus; DNA, Recombinant; Female; Fetal Diseases; Genetic Therapy; Genetic Vectors; Glycerophospholipids; Humans; Infant; Injections, Intraventricular; Liposomes; Male; Mitochondria; Nerve Tissue Proteins; Osmotic Pressure; Phosphatidylethanolamines; Prenatal Diagnosis; Primates; Promoter Regions, Genetic; Protamines; Rats | 1999 |
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
Topics: Acetates; Antacids; Calcinosis; Calcium; Calcium Compounds; Coronary Artery Disease; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2002 |
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.
Topics: Acetates; Calcium Compounds; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders | 2002 |
Phosphate binder usage in kidney failure patients.
Topics: Acetates; Aluminum Compounds; Calcium Carbonate; Calcium Compounds; Clinical Trials as Topic; Epoxy Compounds; Humans; Iron Compounds; Ketoglutaric Acids; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Topics: Acetates; Calcium; Calcium Compounds; Double-Blind Method; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis | 2004 |
Consequences and management of hyperphosphatemia in patients with renal insufficiency.
Topics: Acetates; Calcinosis; Calcium; Calcium Compounds; Cardiovascular Diseases; Diet; Humans; Hyperparathyroidism, Secondary; Phosphates; Renal Dialysis; Renal Insufficiency; Tomography, X-Ray Computed | 2005 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Calcinosis; Calcium Compounds; Coronary Vessels; Disease Progression; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; United States | 2005 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Humans; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
[Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia].
Topics: Acetates; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Design; Gels; Humans; Hyperphosphatemia; Lanthanum; Macromolecular Substances; Phosphorus, Dietary; Polyamines; Polymers; Renal Dialysis; Sevelamer | 2009 |
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Chronic Disease; Humans; Kidney Diseases; Lanthanum; Polyamines; Sevelamer | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Pharmacology, efficacy and safety of oral phosphate binders.
Topics: Acetates; Animals; Calcium Compounds; Chelating Agents; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Intestinal Absorption; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lanthanum; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
Topics: Acetates; Aged; Calcium Carbonate; Calcium Compounds; Cause of Death; Chelating Agents; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chelation Therapy; Diet Therapy; Evidence-Based Medicine; Humans; Hyperphosphatemia; Nephrology; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; United States | 2013 |
Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.
Topics: Acetates; Adult; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperphosphatemia; Male; Renal Dialysis | 2015 |
Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
Topics: Acetates; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Bread; Calcium; Calcium Compounds; Calcium Phosphates; Calcium, Dietary; Dietary Proteins; Fibroblast Growth Factor-23; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2015 |
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Topics: Acetates; Bone Diseases; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis; Sevelamer | 2016 |
36 trial(s) available for phenyl acetate and calcium acetate
| Article | Year |
|---|---|
Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium; Calcium Compounds; Chemistry, Pharmaceutical; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis; Tablets, Enteric-Coated | 1999 |
A preference study: calcium acetate tablets versus gelcaps in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Female; Gels; Humans; Kidney Failure, Chronic; Male; Middle Aged; Patient Satisfaction; Phosphates; Renal Dialysis; Tablets; Treatment Refusal | 2002 |
Effect of phosphate binders on supplemental iron absorption in healthy subjects.
Topics: Acetates; Administration, Oral; Adolescent; Adult; Biological Availability; Calcium Carbonate; Calcium Compounds; Cross-Over Studies; Drug Interactions; Epoxy Compounds; Female; Humans; Intestinal Absorption; Iron; Male; Phosphates; Polyamines; Polyethylenes; Sevelamer | 2002 |
Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Compounds; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.
Topics: Acetates; Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Calcium Compounds; Chromatography, High Pressure Liquid; Ciprofloxacin; Cross-Over Studies; Depression, Chemical; Drug Interactions; Drug Resistance, Bacterial; Epoxy Compounds; Female; Humans; Intestinal Absorption; Male; Polyamines; Polyethylenes; Sevelamer | 2003 |
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Topics: Acetates; Aortic Valve; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Heart Valve Diseases; Humans; Kidney Failure, Chronic; Mitral Valve; Multivariate Analysis; Renal Dialysis; Tomography, X-Ray Computed | 2004 |
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study).
Topics: Acetates; Adult; Aged; Bicarbonates; Calcium; Calcium Compounds; Double-Blind Method; Epoxy Compounds; Female; Humans; Hypercalcemia; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Polyethylenes; Prospective Studies; Renal Dialysis; Sevelamer | 2004 |
Calcium-enriched bread for treatment of uremic hyperphosphatemia.
Topics: Acetates; Bread; Calcium; Calcium Compounds; Calcium, Dietary; Diet Records; Female; Food, Fortified; Humans; Male; Middle Aged; Patient Compliance; Phosphates; Phosphorus, Dietary; Renal Dialysis; Uremia | 2004 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.
Topics: Acetates; Adolescent; Calcium Compounds; Child; Child, Preschool; Chronic Disease; Cross-Over Studies; Female; Humans; Infant; Kidney Diseases; Male; Polyamines; Sevelamer | 2006 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Remodeling; Calcium; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Research Design; Sevelamer; Treatment Outcome | 2006 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.
Topics: Acetates; Adult; alpha-2-HS-Glycoprotein; Blood Proteins; C-Reactive Protein; Calcinosis; Calcium; Calcium Compounds; Chelating Agents; Endothelium, Vascular; Homeostasis; Humans; Middle Aged; Phosphates; Polyamines; Prospective Studies; Renal Insufficiency, Chronic; Sevelamer; Treatment Outcome; Vascular Diseases; Vasodilation | 2008 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
Topics: Acetates; Adult; Biopsy; Bone Remodeling; Brazil; Calcium Compounds; Chelating Agents; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Polyamines; Practice Guidelines as Topic; Prospective Studies; Reference Values; Renal Dialysis; Sevelamer | 2008 |
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Female; Hemodialysis Solutions; Hospitalization; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2008 |
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Topics: Acetates; Anticholesteremic Agents; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Heptanoic Acids; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Renal Dialysis; Sevelamer; Time Factors | 2008 |
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Topics: Acetates; Adult; Aged; Calcium Compounds; Chelating Agents; Drug Tolerance; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Polyamines; Sevelamer | 2009 |
Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
Topics: Acetates; Bone Remodeling; Brazil; Calcinosis; Calcium Compounds; Chelating Agents; Comorbidity; Coronary Artery Disease; Female; Humans; Incidence; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2008 |
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Follow-Up Studies; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Medicaid; Medicare; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome; United States | 2009 |
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
Topics: Acetates; Adult; Biomarkers; Bone Diseases, Metabolic; Calcium Compounds; Chelating Agents; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Sevelamer; Time Factors; Treatment Outcome | 2010 |
Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.
Topics: Acetates; Calcium Compounds; Chelating Agents; Child; Child, Preschool; Chronic Disease; Female; Humans; Kidney Diseases; Male; Polyamines; Sevelamer; Severity of Illness Index; Time Factors | 2010 |
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium Compounds; Female; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed | 2011 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease.
Topics: Acetates; Calcium; Calcium Compounds; Chelating Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Intention to Treat Analysis; Male; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2011 |
Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
Topics: Acetates; Adult; Aged; C-Reactive Protein; Calcium Compounds; Chelating Agents; Endotoxins; Female; Humans; Interleukin-6; Lipopolysaccharide Receptors; Male; Middle Aged; Phosphates; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer | 2011 |
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.
Topics: Acetates; Adult; Calcium Compounds; Chelating Agents; Chronic Disease; Comorbidity; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forearm; Humans; Hyperphosphatemia; Kidney Diseases; Middle Aged; Phosphates; Polyamines; Prospective Studies; Regional Blood Flow; Sevelamer; Severity of Illness Index; Treatment Outcome; Vasodilation | 2012 |
Effects of phosphate binders in moderate CKD.
Topics: Acetates; Aged; Aged, 80 and over; Bone Density; Calcium Compounds; Chelating Agents; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphates; Pilot Projects; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2012 |
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium Compounds; Chelating Agents; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Kidney Function Tests; Magnesium; Male; Middle Aged; Parathyroid Hormone; Polyamines; Prognosis; Renal Dialysis; Risk Factors; Sevelamer; Young Adult | 2013 |
Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.
Topics: Acetates; Adaptor Proteins, Signal Transducing; Adiponectin; beta Catenin; Biomarkers; Bone Density; Bone Diseases; Bone Morphogenetic Proteins; Calcium Compounds; Chelating Agents; Energy Metabolism; Female; Fibroblast Growth Factor-23; Genetic Markers; Humans; Intercellular Signaling Peptides and Proteins; Leptin; Male; Middle Aged; Polyamines; Renal Insufficiency, Chronic; Serotonin; Sevelamer; Wnt Proteins | 2013 |
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Topics: Acetates; Aged; Calcium; Calcium Compounds; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2015 |
Differential effects of phosphate binders on vitamin D metabolism in chronic kidney disease.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Double-Blind Method; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Phosphates; Prognosis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2020 |
Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals.
Topics: Acetates; Calcium Compounds; Chelating Agents; Glycine; Humans; Isoquinolines; Phosphates; Sevelamer | 2021 |
Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study.
Topics: Acetates; Calcium Compounds; Drug Combinations; Ferric Compounds; Gastrointestinal Microbiome; Humans; Hyperphosphatemia; Pilot Projects; Renal Dialysis; RNA, Ribosomal, 16S; Sucrose | 2022 |
123 other study(ies) available for phenyl acetate and calcium acetate
| Article | Year |
|---|---|
Analysis of carboxyl content in oxidized celluloses by solid-state 13C CP/MAS NMR spectroscopy.
Topics: Acetates; Calcium Compounds; Carboxylic Acids; Cellulose; Gossypium; Magnetic Resonance Spectroscopy; Oxidation-Reduction | 1999 |
Phosphate-binding capacity of ferrihydrite versus calcium acetate in rats.
Topics: Absorption; Acetates; Animals; Calcium Compounds; Dose-Response Relationship, Drug; Ferric Compounds; Ferritins; Male; Phosphates; Rats; Rats, Sprague-Dawley | 1999 |
The crossover comparative trial of calcium acetate versus sevelamer hydrochloride (Renagel) as phosphate binders in dialysis patients.
Topics: Acetates; Calcifediol; Calcinosis; Calcium; Calcium Compounds; Capsules; Cardiovascular Diseases; Cross-Over Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2000 |
Phosphate binders do not compromise the copper status of adult renal disease patients on hemodialysis.
Topics: Acetates; Adult; Aged; Aluminum Hydroxide; Antacids; Calcium Carbonate; Calcium Compounds; Ceruloplasmin; Copper; Erythrocytes; Female; Humans; Male; Middle Aged; Nutritional Physiological Phenomena; Phosphorus; Renal Dialysis; Renal Insufficiency; Superoxide Dismutase | 2000 |
Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
Topics: Acetates; Aluminum; Aluminum Hydroxide; Cadmium; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Case-Control Studies; Chelating Agents; Chi-Square Distribution; Copper; Cross-Sectional Studies; Erythropoietin; Female; Hematocrit; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Lead; Male; Mercury; Metals; Middle Aged; Phosphates; Renal Dialysis; Spectrophotometry, Atomic; Sucralfate; Trace Elements; Zinc | 2000 |
Developing porosity of poly(propylene glycol-co-fumaric acid) bone graft substitutes and the effect on osteointegration: a preliminary histology study in rats.
Topics: Acetates; Animals; Bone and Bones; Bone Development; Bone Transplantation; Calcium; Calcium Compounds; Durapatite; Kinetics; Male; Polymers; Propylene Glycols; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Tibia; Time Factors | 2000 |
Osteoporosis and mild metabolic acidosis in the rat after orchiectomy and their prevention: should prophylactic therapy be administered to patients with androgen deprivation?
Topics: Acetates; Acidosis; Androgens; Animals; Bone and Bones; Bone Density; Calcium; Calcium Compounds; Citrates; Femoral Fractures; Hydrogen-Ion Concentration; Intestinal Absorption; Magnesium; Male; Orchiectomy; Osteoporosis; Phosphorus; Rats; Rats, Sprague-Dawley; Sodium Citrate; Stress, Mechanical | 2001 |
Crystallization of a complex between human CDK6 and a virus-encoded cyclin is critically dependent on the addition of small charged organic molecules.
Topics: Acetates; Calcium Compounds; Crystallization; Crystallography, X-Ray; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinases; Cyclins; Herpesvirus 2, Saimiriine; Humans; Protein Conformation; Protein Serine-Threonine Kinases; Viral Proteins | 2001 |
Calcium on trial: beyond a reasonable doubt?
Topics: Acetates; Calcium; Calcium Carbonate; Calcium Compounds; Humans; Hypercalcemia; Kidney Failure, Chronic; Renal Dialysis | 2003 |
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey.
Topics: Acetates; Bone and Bones; Calcium Carbonate; Calcium Compounds; Dietetics; Epoxy Compounds; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphates; Phosphorus, Dietary; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2003 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
Renal disease medications and evidence-biased medicine.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Evidence-Based Medicine; Humans; Kidney Diseases | 2003 |
[Reaction of cow and human milk to acetate-calcium reagent].
Topics: Acetates; Animals; Calcium; Calcium Compounds; Cattle; Female; Humans; Milk, Human | 1952 |
Sensitization by dihydrotachysterol (DHT) and calcium acetate for the induction of cardiac lesions by various agents.
Topics: Acetates; Calcium; Calcium Compounds; Cardiovascular Diseases; Dihydrotachysterol; Humans; Myocarditis | 1959 |
A calcifying cardiopathy produced by stress and calcium acetate.
Topics: Acetates; Calcification, Physiologic; Calcium Compounds; Disease; Heart Diseases; Myocardium; Stress, Physiological | 1961 |
CYST FORMATION IN THE PARATHYROIDS AND MUSCULAR DYSTROPHY INDUCED BY DIHYDROTACHYSTEROL AND CALCIUM ACETATE.
Topics: Acetates; Calcium Compounds; Calcium, Dietary; Cysts; Dihydrotachysterol; Muscular Dystrophies; Parathyroid Glands; Pathology; Pharmacology; Rats; Research; Toxicology | 1964 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Calcium bioavailability and kinetics of calcium ascorbate and calcium acetate in rats.
Topics: Absorption; Acetates; Administration, Oral; Animals; Ascorbic Acid; Biological Availability; Calcium; Calcium Compounds; Calcium Radioisotopes; Feces; Femur; Injections, Intravenous; Male; Models, Biological; Rats; Rats, Sprague-Dawley | 2004 |
Nutrient removal of ammonia rich effluents in a sequencing batch reactor.
Topics: Acetates; Ammonia; Bioreactors; Calcium Compounds; Nitrogen; Oxygen; Waste Disposal, Fluid | 2003 |
On the sensitivity of the methane fermentation of calcium acetate towards some toxic substances.
Topics: Acetates; Calcium Compounds; Fermentation; Humans; Methane | 1951 |
Production of experimental encephalomyelitis with calcium acetate compound extracted from brain tissue.
Topics: Acetates; Animals; Brain; Calcium Compounds; Encephalomyelitis | 1951 |
Application of central composite design and response surface methodology to the fermentation of olive juice by Lactobacillus plantarum and Debaryomyces hansenii.
Topics: Acetates; Calcium Compounds; Fermentation; Food Handling; Food Microbiology; Lactates; Lactobacillus; Mathematics; Olea; Osmolar Concentration; Potassium Chloride; Saccharomycetales; Sodium Chloride; Temperature; Time Factors | 2004 |
The influence of sulphite on the methane fermentation of sodium and calcium acetates.
Topics: Acetates; Calcium Compounds; Fermentation; Humans; Methane; Sodium; Sulfites | 1949 |
[MIBI and parathyroid gland function in secondary hyperparathyroidism].
Topics: Acetates; Adult; Aged; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Secretory Rate; Technetium Tc 99m Sestamibi; Uremia | 2004 |
Phosphate intake and the CARE study.
Topics: Acetates; Calcium Compounds; Diet; Humans; Phosphates; Polyamines; Renal Dialysis | 2004 |
Calcium acetate-induced linear fixed drug eruption.
Topics: Acetates; Calcium Compounds; Diagnosis, Differential; Drug Eruptions; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2005 |
Precipitation of hydroxyapatite nanoparticles: effects of precipitation method on electrophoretic deposition.
Topics: Acetates; Acids; Calcium Compounds; Chemical Precipitation; Coated Materials, Biocompatible; Durapatite; Electrophoresis; Nanostructures | 2005 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Synthesis of bioactive PMMA bone cement via modification with methacryloxypropyltri-methoxysilane and calcium acetate.
Topics: Acetates; Adhesiveness; Apatites; Body Fluids; Bone Cements; Bone Substitutes; Calcium Compounds; Compressive Strength; Elasticity; Hardness; Materials Testing; Methacrylates; Molecular Weight; Particle Size; Polymethyl Methacrylate; Powders; Silanes; Transition Temperature | 2005 |
Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain.
Topics: Acetates; Animals; Aspartic Acid; Brain; Calcium Compounds; Canavan Disease; Liver; Male; Mice; Mice, Inbred C57BL | 2005 |
Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients.
Topics: Acetates; Adult; Aged; Blood Pressure; Calcium Compounds; Cross-Sectional Studies; Diet, Mediterranean; Erythropoietin; Female; Ferritins; Hematocrit; Humans; Iron; Male; Middle Aged; Renal Dialysis; Seafood; Vegetables; Weight Gain | 2005 |
Phosphate binders.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2006 |
Preparation and characterization of anodized titanium surfaces and their effect on osteoblast responses.
Topics: Acetates; Alkaline Phosphatase; Calcium; Calcium Compounds; Calcium Phosphates; Cell Differentiation; Cells, Cultured; Coated Materials, Biocompatible; Electrochemistry; Electron Probe Microanalysis; Glycerophosphates; Humans; Materials Testing; Microscopy, Electron, Scanning; Osteoblasts; Phenotype; Surface Properties; Titanium; X-Ray Diffraction | 2006 |
Mechanical and histological evaluation of a PMMA-based bone cement modified with gamma-methacryloxypropyltrimethoxysilane and calcium acetate.
Topics: Acetates; Animals; Body Fluids; Bone Cements; Bone Substitutes; Calcium Compounds; Compressive Strength; Dogs; Female; Femur; Hardness; Materials Testing; Methacrylates; Osseointegration; Polymethyl Methacrylate; Silanes; Surface Properties | 2006 |
Phosphate binders.
Topics: Acetates; Calcium Compounds; Double-Blind Method; Phosphates; Polyamines; Prospective Studies; Randomized Controlled Trials as Topic; Sevelamer; United States | 2006 |
The CARE study and cardiovascular calcification.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiomyopathies; Humans; United States | 2006 |
Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Conflict, Psychological; Disease Management; Humans; Kidney Failure, Chronic; Phosphates; Treatment Outcome; United States | 2006 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |
Conductance study of association in aqueous CaCl2, Ca(CH3COO)2, and Ca(CH3COO)2.nCH3COOH from 348 to 523 K at 10 MPa.
Topics: Acetates; Acetic Acid; Calcium Chloride; Calcium Compounds; Electric Conductivity; Models, Chemical; Pressure; Temperature; Water | 2005 |
[Effects of voltage during anodization on titanium surface on cell attachment and spreading of osteoblasts].
Topics: Acetates; Calcium Compounds; Cell Adhesion; Electrochemistry; Electroplating; Humans; Osteoblasts; Oxidation-Reduction; Surface Properties; Titanium | 2006 |
Development of polysaccharide gel coated pellets for oral administration 1. Physico-mechanical properties.
Topics: Acetates; Administration, Oral; Alginates; Calcium Compounds; Cellulose; Chemistry, Pharmaceutical; Gels; Glucuronic Acid; Materials Testing; Microscopy, Electron, Scanning; Particle Size; Pectins; Polysaccharides; Tensile Strength; Theophylline | 2006 |
A spectroscopic study of the mineral paceite (calcium acetate).
Topics: Acetates; Calcium Compounds; Microscopy, Electron, Scanning; Minerals; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermogravimetry; Water; X-Ray Diffraction | 2007 |
[Fluorine removal efficiency of organic-calcium during coal combustion].
Topics: Absorption; Acetates; Air Pollutants; Calcium Carbonate; Calcium Compounds; Coal; Fluorine; Hot Temperature; Sulfur; Waste Management | 2006 |
Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement.
Topics: Acetates; Aged; Calcium Carbonate; Calcium Compounds; Female; Humans; Male; Phosphates; Thyrotropin; Thyroxine | 2007 |
Swelling, erosion and release behavior of alginate-based matrix tablets.
Topics: Acetates; Alginates; Calcium Compounds; Glucuronic Acid; Hardness; Hexuronic Acids; Hydrogen-Ion Concentration; Metronidazole; Particle Size; Sodium Bicarbonate; Solubility; Tablets | 2007 |
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Topics: Acetates; Ammonium Sulfate; Arylsulfonates; Calcium Compounds; Cisplatin; Delayed-Action Preparations; Doxorubicin; Liposomes; Methylprednisolone Hemisuccinate; Ultrasonics | 2007 |
Novel zinc-based fixative for high quality DNA, RNA and protein analysis.
Topics: Acetates; Animals; Calcium Compounds; Chlorides; DNA; Electrophoresis, Gel, Two-Dimensional; Female; Fixatives; Formaldehyde; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Paraffin Embedding; Polymerase Chain Reaction; Proteins; Proteomics; RNA; Tissue Fixation; Trifluoroacetic Acid; Zinc; Zinc Compounds | 2007 |
Pursuing structure in microcrystalline solids with independent molecules in the unit cell using 1H-13C correlation data.
Topics: Acetates; Calcium Compounds; Carbon Isotopes; Catechin; Hydrogen; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Structure; Santonin | 2007 |
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Topics: Acetates; Calcium Compounds; Chelating Agents; Hemodialysis Solutions; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Research Design; Sevelamer | 2008 |
Preparation, characterization, and evaluation of liposomal ferulic acid in vitro and in vivo.
Topics: Acetates; Animals; Brain; Calcium Compounds; Chromatography, High Pressure Liquid; Coumaric Acids; Drug Compounding; Drug Stability; Glycine max; Liposomes; Male; Phosphatidylcholines; Rats; Rats, Wistar; Solubility; Spectrophotometry, Ultraviolet; Tissue Distribution | 2008 |
In vivo response of bioactive PMMA-based bone cement modified with alkoxysilane and calcium acetate.
Topics: Acetates; Alcohols; Animals; Bone Cements; Calcium Compounds; Fracture Healing; Male; Materials Testing; Polymethyl Methacrylate; Rabbits; Silanes; Tibial Fractures; Treatment Outcome | 2008 |
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.
Topics: Acetates; Adult; Bone Remodeling; Calcinosis; Calcium Compounds; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
[Pore structure and desulfurization characteristics of organic calcium].
Topics: Acetates; Air Pollutants; Calcium Compounds; Hydrogen Sulfide; Organic Chemicals; Porosity; Sulfur Dioxide | 2008 |
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Humans; Polyamines; Sevelamer | 2008 |
Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Polyamines; Sevelamer | 2008 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
Topics: Acetates; Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Calcium Compounds; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Renal Dialysis | 2009 |
Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients.
Topics: Acetates; Adult; Biomarkers; Calcium Compounds; Female; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Oxidative Stress; Phosphate-Binding Proteins; Polyamines; Reactive Oxygen Species; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Allosteric modulation of Ras positions Q61 for a direct role in catalysis.
Topics: Acetates; Allosteric Regulation; Allosteric Site; Biocatalysis; Calcium; Calcium Compounds; Catalytic Domain; Crystallography, X-Ray; Enzyme Stability; Glutamine; Hydrogen Bonding; Hydrolysis; Hydroxyl Radical; Magnesium; Models, Molecular; Protein Structure, Tertiary; ras Proteins; Structure-Activity Relationship | 2010 |
Relative transcription of Listeria monocytogenes virulence genes in liver pâtés with varying NaCl content.
Topics: Acetates; Animals; Calcium Compounds; Food Microbiology; Gene Expression; Genes, Bacterial; Lactates; Listeria monocytogenes; Meat Products; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial; Salt Tolerance; Sodium Chloride; Swine; Transcription, Genetic; Virulence | 2010 |
A new process for producing calcium acetate from vegetable wastes for use as an environmentally friendly deicer.
Topics: Acetates; Acetic Acid; Bioreactors; Calcium Compounds; Carbon; Conservation of Natural Resources; Dialysis; Electrochemical Techniques; Environment; Membranes, Artificial; Osmosis; Rheology; Solutions; Vegetables; Waste Products | 2010 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
[Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control].
Topics: Acetates; Aged; Aluminum Hydroxide; Calcium Compounds; Chelating Agents; Chelation Therapy; Cohort Studies; Cross-Sectional Studies; Dyspepsia; Female; Health Knowledge, Attitudes, Practice; Humans; Lanthanum; Male; Middle Aged; Patient Compliance; Patient Preference; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Tablets; Taste | 2010 |
Stomach calcification revealed by gastrofibroscopy in a haemodialysis patient.
Topics: Acetates; Biopsy; Calcinosis; Calcium Compounds; Chelating Agents; Fiber Optic Technology; Gastroscopy; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stomach Diseases; Vitamin D; Vitamins | 2010 |
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiography; Renal Dialysis; Risk Factors; Serum Albumin; Sex Factors; Vascular Calcification | 2011 |
Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients.
Topics: Acetates; Adult; Aged; Calcium Carbonate; Calcium Compounds; Cohort Studies; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2011 |
Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
Topics: Acetates; Alginates; Calcium Carbonate; Calcium Compounds; Calorimetry, Differential Scanning; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Drug Design; Gastric Juice; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Intestinal Secretions; Intestines; Kinetics; Microscopy, Electron, Scanning; Models, Biological; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical | 2011 |
Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy.
Topics: Acetates; Administration, Oral; Aged; Biopsy; Calcium Compounds; Creatinine; Female; Humans; Hypophosphatemia; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Phosphates; Renal Insufficiency; Treatment Outcome | 2011 |
Effects of six chemical deicers on larval wood frogs (Rana sylvatica).
Topics: Acetates; Animals; Calcium Chloride; Calcium Compounds; Chlorides; Ecosystem; Fresh Water; Larva; Magnesium Chloride; Ranidae; Salinity; Sodium Chloride; Transportation; Water Pollutants, Chemical | 2011 |
Spontaneous bilateral humeral shaft fracture due to severe renal osteodystrophia.
Topics: Acetates; Adenoma; Adult; Calcitriol; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Humeral Fractures; Parathyroid Hormone; Parathyroid Neoplasms; Radiography; Renal Dialysis; Renal Insufficiency; Treatment Outcome | 2011 |
Absorption of levothyroxine when coadministered with various calcium formulations.
Topics: Absorption; Acetates; Adolescent; Adult; Calcium Carbonate; Calcium Citrate; Calcium Compounds; Calcium, Dietary; Drug Interactions; Drug Synergism; Female; Humans; Male; Thyroid Gland; Thyroxine | 2011 |
Fluorescence investigation of the retinal delivery of hydrophilic compounds via liposomal eyedrops.
Topics: Acetates; Animals; Biological Transport; Calcium Compounds; Cell Line; Conjunctiva; Drug Compounding; Drug Delivery Systems; Feasibility Studies; Fluoresceins; Fluorescent Dyes; Humans; Hydrophobic and Hydrophilic Interactions; Indicators and Reagents; Liposomes; Male; Mice; Mice, Inbred Strains; Ophthalmic Solutions; Pharmaceutical Vehicles; Phosphatidylcholines; Retina | 2011 |
Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
Topics: Acetates; Calcium Compounds; Dietary Supplements; Endothelium, Vascular; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Forearm; Humans; Kidney Diseases; Male; Polyamines; Regional Blood Flow; Renal Dialysis; Sevelamer; Vitamin K 2; Vitamin K Deficiency | 2012 |
Sustained-release alginate-chitosan pellets prepared by melt pelletization technique.
Topics: Acetates; Alginates; Biocompatible Materials; Calcium Compounds; Chitosan; Drug Carriers; Drug Compounding; Drug Implants; Solubility; Spectroscopy, Fourier Transform Infrared | 2012 |
Hydrothermally mixed hydroxyapatite-multiwall carbon nanotubes composite coatings on biomedical alloys by electrophoretic deposition.
Topics: Acetates; Alloys; Calcium Compounds; Durapatite; Electrophoresis; Nanotubes, Carbon; Phosphoric Acids; Surface Properties; Temperature; Titanium | 2013 |
Phosphate binders in CKD: bad news or good news?
Topics: Acetates; Calcium Compounds; Chelating Agents; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
Shift in the equilibrium between on and off states of the allosteric switch in Ras-GppNHp affected by small molecules and bulk solvent composition.
Topics: Acetates; Allosteric Regulation; Allosteric Site; Calcium Compounds; Catalytic Domain; Dithioerythritol; Dithiothreitol; Enzyme Stability; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Hydrolysis; Isoenzymes; Models, Molecular; Polyethylene Glycols; Protein Structure, Secondary; ras Proteins; Small Molecule Libraries; Solutions; Solvents | 2012 |
The adequacy of phosphorus binder prescriptions among American hemodialysis patients.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; United States | 2012 |
Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
Topics: Acetates; Blood Vessels; Calcinosis; Calcium Compounds; Chelating Agents; Disease Progression; Humans; Hyperphosphatemia; Lanthanum; Phosphate-Binding Proteins; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2012 |
Parathyromatosis.
Topics: Acetates; Adenoma; Biomarkers; Calcitriol; Calcium Compounds; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Reoperation; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Up-Regulation | 2012 |
Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysis.
Topics: Acetates; Calcium Compounds; Chelating Agents; Confidence Intervals; Female; Hospitalization; Humans; Hyperphosphatemia; Male; Markov Chains; Middle Aged; Outcome Assessment, Health Care; Patient Compliance; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer | 2013 |
Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients.
Topics: Acetates; Adult; Calcium; Calcium Compounds; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphates; Renal Dialysis; Young Adult | 1990 |
Properties of liquids and dusts: how do they influence dermal loading during immersion, deposition, and surface contact exposure pathways?
Topics: Acetates; Calcium Compounds; Dermis; Dust; Environmental Monitoring; Female; Glycerol; Hand; Humans; Immersion; Male; Occupational Exposure; Skin Absorption; Viscosity; Zinc Oxide | 2013 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
Effects of phosphates on microstructure and bioactivity of micro-arc oxidized calcium phosphate coatings on Mg-Zn-Zr magnesium alloy.
Topics: Acetates; Adult; Alloys; Animals; Body Fluids; Calcium Compounds; Calcium Phosphates; Electrolytes; Female; Fluorides; Humans; Hydrogen-Ion Concentration; Immersion; Ions; Magnesium; Male; Mice; Mice, Inbred Strains; Molecular Structure; Oxidation-Reduction; Phosphates; Surface Properties; Time Factors; Water; Zinc; Zirconium | 2013 |
Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders: effect on mortality in patients with CKD.
Topics: Acetates; Calcium Compounds; Chelating Agents; Global Health; Humans; Phosphates; Renal Insufficiency, Chronic; Retrospective Studies; Survival Rate | 2013 |
A preliminary comparison of three dermal exposure sampling methods: rinses, wipes and cotton gloves.
Topics: Acetates; Calcium Compounds; Environmental Exposure; Gloves, Protective; Hand Disinfection; Humans; Salts; Skin; Zinc Oxide | 2014 |
Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Female; Humans; Hyperphosphatemia; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Medicare Part D; Polyamines; Renal Dialysis; Sevelamer; Survival Rate; Treatment Outcome; United States | 2014 |
Reasons for phosphate binder discontinuation vary by binder type.
Topics: Acetates; Adult; Aged; Calcium Compounds; Female; Gastrointestinal Tract; Humans; Hypercalcemia; Hypophosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Treatment Outcome; United States | 2014 |
Interaction of charged amino-acid side chains with ions: an optimization strategy for classical force fields.
Topics: Acetates; Amino Acids; Calcium Compounds; Hydrogen Bonding; Ions; Molecular Dynamics Simulation; Static Electricity; Thermodynamics; Water | 2014 |
The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.
Topics: Acetates; Aluminum Hydroxide; Calcium Compounds; Drug Substitution; Female; Humans; Magnesium; Male; Middle Aged; Phosphorus; Renal Dialysis | 2014 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetates; Anti-Bacterial Agents; beta-Cyclodextrins; Calcium Compounds; Computer Simulation; Cryoelectron Microscopy; Drug Carriers; Drug Compounding; Drug Design; Drug Liberation; Excipients; Liposomes; Mupirocin; Nanostructures; Particle Size; Polyethylene Glycols; Propylene Glycol; Solubility; Surface Properties | 2014 |
Biotribocorrosion (tribo-electrochemical) characterization of anodized titanium biomaterial containing calcium and phosphorus before and after osteoblastic cell culture.
Topics: Acetates; Alkaline Phosphatase; Bone Neoplasms; Calcium Compounds; Cell Differentiation; Cell Line, Tumor; Cell Shape; Coated Materials, Biocompatible; Corrosion; Dental Materials; Electrochemistry; Friction; Glycerophosphates; Humans; Hydrophobic and Hydrophilic Interactions; Materials Testing; Osseointegration; Osteoblasts; Osteosarcoma; Oxidation-Reduction; Oxides; Phosphates; Phosphorus; Titanium | 2015 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |
Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow up.
Topics: Acetates; Calcium Compounds; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
Thermogravimetric investigation on characteristic of biomass combustion under the effect of organic calcium compounds.
Topics: Acetates; Arachis; Biofuels; Biomass; Calcium; Calcium Compounds; Industrial Waste; Kinetics; Oryza; Sulfur; Thermogravimetry; Triticum | 2015 |
Bioactive polymethylmethacrylate bone cement modified with combinations of phosphate group-containing monomers and calcium acetate.
Topics: Acetates; Apatites; Body Fluids; Bone Cements; Calcium Compounds; Compressive Strength; Humans; In Vitro Techniques; Materials Testing; Microscopy, Electron, Scanning; Polymethyl Methacrylate; Surface Properties; X-Ray Diffraction | 2015 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
Ionization controls for biomineralization-inspired CO2 chemical looping at constant room temperature.
Topics: Acetates; Calcium Compounds; Carbon Dioxide; Ethanol; Models, Biological; Nanoparticles; Temperature; Water | 2015 |
Design of cissus-alginate microbeads revealing mucoprotection properties in anti-inflammatory therapy.
Topics: Acetates; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Compounds; Carrageenan; Delayed-Action Preparations; Diclofenac; Drug Compounding; Drug Liberation; Edema; Factor Analysis, Statistical; Glucuronic Acid; Hexuronic Acids; Hindlimb; Kinetics; Male; Microspheres; Particle Size; Plant Gums; Rats; Stomach | 2015 |
Drug release, preclinical and clinical pharmacokinetics relationships of alginate pellets prepared by melt technology.
Topics: Acetates; Alginates; Calcium Carbonate; Calcium Compounds; Chlorpheniramine; Drug Liberation; Excipients; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Solubility; Technology, Pharmaceutical | 2016 |
Recycling of typical supercapacitor materials.
Topics: Acetates; Acetonitriles; Aluminum; Borates; Calcium Compounds; Charcoal; Chemical Fractionation; Electric Power Supplies; Nanotubes, Carbon; Quaternary Ammonium Compounds; Recycling; Solid Waste; Solvents | 2016 |
Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Cardiovascular Diseases; Humans; Magnesium; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2016 |
In vivo study of osteogenerating properties of calcium-phosphate coating on titanium alloy Ti-6Al-4V.
Topics: Acetates; Alloys; Animals; Calcium Compounds; Calcium Phosphates; Coated Materials, Biocompatible; Disease Models, Animal; Durapatite; Femoral Fractures; Glycerophosphates; Male; Osteogenesis; Prostheses and Implants; Rats; Rats, Wistar; Surface Properties; Titanium | 2016 |
A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients.
Topics: Acetates; Adult; Aged; Asian People; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Female; Hospitalization; Humans; Male; Markov Chains; Middle Aged; National Health Programs; Prospective Studies; Quality-Adjusted Life Years; Regression Analysis; Renal Dialysis; Renal Insufficiency, Chronic; Republic of Korea; Sevelamer | 2018 |
Rapid Screening of Natural Plant Extracts with Calcium Diacetate for Differential Effects Against Foodborne Pathogens and a Probiotic Bacterium.
Topics: Acetates; Anti-Bacterial Agents; Calcium Compounds; Citrus sinensis; Colony Count, Microbial; Escherichia coli O157; Food Contamination; Food Microbiology; Hydrogen-Ion Concentration; Lactobacillus plantarum; Listeria monocytogenes; Microbial Sensitivity Tests; Microbial Viability; Plant Extracts; Probiotics; Salmonella typhimurium; Staphylococcus aureus; Vaccinium macrocarpon | 2017 |
Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Drug Combinations; Ferric Compounds; Hydrogen-Ion Concentration; Kinetics; Lanthanum; Magnesium; Phosphates; Sevelamer; Sucrose | 2019 |
Phosphate binder choices used in ESRD patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium Compounds; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Retrospective Studies; Sevelamer; Young Adult | 2016 |
Removal of inorganic chemical species and organic matter from slaughterhouse wastewater via calcium acetate synthesized from eggshell.
Topics: Abattoirs; Acetates; Animals; Calcium Compounds; Egg Shell; Oxides; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2019 |
Calcium acetate-induced reduction of cadmium accumulation in Oryza sativa: Expression of auto-inhibited calcium-ATPase and cadmium transporters.
Topics: Acetates; Adenosine Triphosphatases; Cadmium; Calcium; Calcium Compounds; Calcium-Transporting ATPases; Gene Expression Regulation, Plant; Oryza; Plant Proteins | 2019 |
Preparation and Characterization of the Biological Compound Effervescent Granule of Calcium Acetate.
Topics: Acetates; Biological Availability; Calcium Compounds; Citric Acid; Dietary Supplements; Dosage Forms; Drug Compounding; Particle Size; Polyethylene Glycols; Sodium Bicarbonate | 2019 |
Cooperative effects of slight acidic electrolyzed water combined with calcium sources on tissue calcium content, quality attributes, and bioactive compounds of 'Jiancui' jujube.
Topics: Acetates; Calcium; Calcium Compounds; Electrolysis; Food Preservation; Food Preservatives; Food Storage; Fruit; Nitrates; Quality Control; Water; Ziziphus | 2020 |
Diet-induced oxalate nephropathy.
Topics: Acetates; Acute Kidney Injury; Aged, 80 and over; Calcium Compounds; Diagnosis, Differential; Diet; Humans; Male; Oxalates | 2019 |
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.
Topics: Acetates; Aged, 80 and over; Calcium Compounds; Carcinoma, Renal Cell; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Humans; Indazoles; Kidney Failure, Chronic; Kidney Neoplasms; Male; Oxalates; Pancreatic Neoplasms; Pancrelipase; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis; Sulfonamides; Treatment Outcome | 2019 |
Instant Thermal Switching from Soft Hydrogel to Rigid Plastics Inspired by Thermophile Proteins.
Topics: Acetates; Calcium Compounds; Hardness; Humans; Hydrogels; Hydrophobic and Hydrophilic Interactions; Plastics; Polymers; Protective Devices; Proteins; Temperature | 2020 |
Application of zinc and calcium acetate to precipitate milk fat globule membrane components from a dairy by-product.
Topics: Acetates; Animals; Calcium Compounds; Ethanol; Fractional Precipitation; Glycolipids; Glycoproteins; Hot Temperature; Hydrogen-Ion Concentration; Lipid Droplets; Membranes; Milk Proteins; Phospholipids; Solubility; Zinc | 2020 |
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges.
Topics: Acetates; Calcium Compounds; Cell Line; Chemistry, Pharmaceutical; Dexamethasone; Drug Delivery Systems; Drug Liberation; Humans; Liposomes; Microfluidics; Particle Size | 2020 |
Evaluation of Mechanical Activation and Chemical Synthesis for Particle Size Modification of White Mineral Trioxide Aggregate.
Topics: Acetates; Aluminum Compounds; Calcium Compounds; Drug Combinations; Humans; Materials Testing; Oxides; Particle Size; Root Canal Filling Materials; Silicates; Silicon Dioxide | 2020 |
Investigating mechanical properties and biocement application of CaCO
Topics: Acetates; Bacillaceae; Bone Cements; Calcium Carbonate; Calcium Chloride; Calcium Compounds; Crystallization; Neural Networks, Computer; Nitrates | 2020 |
Preparation of bioactive and antibacterial PMMA-based bone cement by modification with quaternary ammonium and alkoxysilane.
Topics: Acetates; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Calcium Compounds; Compressive Strength; Escherichia coli; Polymethyl Methacrylate; Quaternary Ammonium Compounds; Silanes; Staphylococcus aureus | 2021 |
Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease.
Topics: Acetates; Calcium; Calcium Compounds; Chelating Agents; Humans; Inflammation; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2022 |